Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Chiara, Perfumo"'
Autor:
Gilberto Fronza, Alberto Inga, Michael A. Resnick, David M. Umbach, Debora Russo, Paola Menichini, Yari Ciribilli, Alessandra Bisio, Chiara Perfumo, Paola Monti
Supplementary Tables S1-S5.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::132685bec6202b86b32c5f9b560a6cc4
https://doi.org/10.1158/1541-7786.22519182
https://doi.org/10.1158/1541-7786.22519182
Autor:
David M. Umbach, Paola Menichini, Michael A. Resnick, Alberto Inga, Paola Monti, Chiara Perfumo, Yari Ciribilli, Debora Russo, Alessandra Bisio, Gilberto Fronza
Publikováno v:
Università degli di Trento-IRIS
Germline TP53 mutations result in cancer proneness syndromes known as Li-Fraumeni, Li-Fraumeni-like, and nonsyndromic predisposition with or without family history. To explore genotype/phenotype associations, we previously adopted a functional classi
Autor:
Gilberto Fronza, Riccardo Haupt, Gian Paolo Tonini, Stefano Parodi, Alberto Inga, Raffaella Defferrari, Alberto Garaventa, Chiara Perfumo, Katia Mazzocco
Publikováno v:
Pediatric Blood & Cancer. 55:267-272
Background MDM2 SNP309, characterised by a T-to-G substitution in the MDM2 promoter, is associated with higher gene expression compared to wild type and was recently found to be a negative prognostic factor for patients with stage 4 neuroblastoma (NB
Autor:
Gian Paolo Tonini, R. Defferrari, Riccardo Haupt, Stefano Parodi, Giovanna Bianchi Scarrà, Chiara Perfumo, Alberto Inga, Paola Ghiorzo, Gilberto Fronza, Katia Mazzocco
Publikováno v:
Pediatric Blood & Cancer. 53:576-583
Background MDM2 is a major negative regulator of p53 function and is directly regulated by MYCN in neuroblastoma (NB) cells. MDM2 SNP309, a T-to-G substitution in the MDM2 promoter associated with higher gene expression compared to wild-type, may att
Autor:
Laura Ottini, Bernard Peissel, Carmen J Tartari, Peter Devilee, Silvia Tognazzo, Anders Kvist, Lara Della Puppa, Mara Colombo, Isabella Marchi, Conxi Lázaro, Caterina Vivanet, Jordi Surrallés, Valeria Viassolo, Joseph Vijai, Kenneth Offit, Paolo Radice, Veronica Medici, Ana Osorio, Francesca Spina, Stefania Tommasi, Carlo Tondini, Marina Marchetti, Chiara Corna, Eliseos J. Mucaki, Gabriele Lorenzo Capone, Piera Rizzolo, Maurizio Genuardi, Alessandra Renieri, Jan Hauke, Laura Cortesi, Laura Caleca, Dominique Stoppa-Lyonnet, Paolo Peterlongo, Christi J. van Asperen, Hans Ehrencrona, Fergus J. Couch, Ian G. Campbell, Valeria Pensotti, Irene Catucci, Miguel Angel Pujana, Sylvie Mazoyer, Massimo Federico, Paolo Verderio, Alfons Meindl, Brunella Pilato, Claus R. Bartram, Valentina Dall'Olio, Paul A. James, Massimo Bogliolo, Loris Bernard, Maria Marín, Valérie Sornin, Luisa Balestrino, Gaia Roversi, Judith Balmaña, Marie-Gabrielle Dondon, Simona Agata, Rita K. Schmutzler, Barbara Burwinkel, Viviana Gismondi, Giulia Cini, Ella R. Thompson, Nadine Andrieu, Sara Volorio, Maria Grazia Tibiletti, Francesca Damiola, Harald Surowy, Alessandra Viel, Peter K. Rogan, Laura Matricardi, Anna Laura Putignano, Cristina Verzeroli, Anna Falanga, Chiara Perfumo, Marco Montagna, Margherita Baldassarri, Monica Barile, Riccardo Dolcetti, Florentine Hilbers, Javier Benitez, Laura Papi, Maria Antonietta Mencarelli, Séverine Eon-Marchais, Gillian Mitchell, Orland Diez, Siranoush Manoukian, Maria A. Caligo, Christian Sutter, Gaetana Gambino, Xianshu Wang, Marco A. Pierotti, Bernardo Bonanni, Sara Pizzamiglio, Liliana Varesco, Valentina Silvestri, Olga M. Sinilnikova
Publikováno v:
Biochemistry Publications
Human Molecular Genetics, 24(18), 5345-5355
Human Molecular Genetics, 24(18), 5345-5355
© The Author 2015. Published by Oxford University Press. All rights reserved. Numerous genetic factors that influence breast cancer risk are known. However, approximately two-thirds of the overall familial risk remain unexplained. To determine wheth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd39da8b57dc2d323699626aa2de9678
https://hdl.handle.net/1887/107295
https://hdl.handle.net/1887/107295
Autor:
Marina Grasso, Chiara Perfumo, Paolo Bruzzi, Viviana Gismondi, Elena Gennaro, Loredana Pennese, Maria Teresa Ricci, Liliana Varesco
Publikováno v:
European journal of human genetics : EJHG. 22(2)
The identification of women with a high probability of being carriers of pathogenic BRCA mutation is not straightforward and a major improvement would be the availability of markers of mutations that could be directly evaluated in individuals asking
Autor:
Stefano, Parodi, Chiara, Perfumo, Alberto, Garaventa, Alberto, Inga, Katia, Mazzocco, Raffaella, Defferrari, Gian Paolo, Tonini, Gilberto, Fronza, Riccardo, Haupt
Publikováno v:
Pediatric bloodcancer. 55(2)
MDM2 SNP309, characterised by a T-to-G substitution in the MDM2 promoter, is associated with higher gene expression compared to wild type and was recently found to be a negative prognostic factor for patients with stage 4 neuroblastoma (NB), but not
Autor:
Paola Menichini, Laura Ottaggio, Chiara Perfumo, Paola Monti, Prema Iyer, Debora Russo, Alberto Inga, Gilberto Fronza, Barry Gold
Publikováno v:
DNA repair. 9(7)
Me-lex is a sequence-specific alkylating agent synthesized to preferentially (>90%) generate N3-methyladenine (3-mA) in the minor groove of double-strand DNA, in A-T rich regions. In this paper we investigated the effect of XRCC1 deficiency in the pr
Autor:
Chiara, Perfumo, Stefano, Parodi, Katia, Mazzocco, Raffaella, Defferrari, Alberto, Inga, Giovanna Bianchi, Scarrà, Paola, Ghiorzo, Riccardo, Haupt, Gian Paolo, Tonini, Gilberto, Fronza
MDM2 is a major negative regulator of p53 function and is directly regulated by MYCN in neuroblastoma (NB) cells. MDM2 SNP309, a T-to-G substitution in the MDM2 promoter associated with higher gene expression compared to wild-type, may attenuate the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::21693870b572567d5a9f1d13ca6eb27c
http://hdl.handle.net/11567/266609
http://hdl.handle.net/11567/266609
Autor:
Gian Paolo Tonini, Katia Mazzocco, R. Defferrari, Chiara Perfumo, Gilberto Fronza, Stefano Parodi, Alberto Inga, Riccardo Haupt
Publikováno v:
European journal of cancer (Oxford, England : 1990). 44(17)
Circumvention of the p53 checkpoint in neuroblastoma (NB) might arise from increased expression of its main negative regulator MDM2 . The SNP309, a T-to-G substitution in the MDM2 promoter, was associated with higher levels of MDM2 mRNA and protein,